DNA Vaccine against Hamster Oral Papillomavirus-associated Oral Cancer

Previously we developed a carcinogenesis model involving the combination of 9, 10-dimethyl-1, 2-benzanthracene (DMBA) application with physical wounding of hamster lingual mucosa. The presence of a novel hamster oral papillomavirus (HOPV) was demonstrated and its genome sequenced. In the present stu...

Full description

Saved in:
Bibliographic Details
Published in:Journal of international medical research Vol. 33; no. 6; pp. 647 - 653
Main Authors: Maeda, H, Kubo, K, Sugita, Y, Miyamoto, Y, Komatsu, S, Takeuchi, S, Umebayashi, T, Morikawa, S, Kawanishi, K, Kameyama, Y
Format: Journal Article
Language:English
Published: London, England SAGE Publications 01-11-2005
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previously we developed a carcinogenesis model involving the combination of 9, 10-dimethyl-1, 2-benzanthracene (DMBA) application with physical wounding of hamster lingual mucosa. The presence of a novel hamster oral papillomavirus (HOPV) was demonstrated and its genome sequenced. In the present study, this HOPV hamster model was used to test whether vaccination with the L1 gene could prevent the development of oral carcinoma. DNA plasmids encoding the L1 gene or the vector alone were injected intramuscularly into 20 vaccinated and 20 control hamsters, respectively. The lingual tips of the hamsters were painted with DMBA for 8 weeks. A portion of the lingual tips was excised, and the tips were then painted daily with DMBA until the animals were killed 13 days later. All control hamsters developed lingual carcinoma, whereas 12 of the L1-vaccinated hamsters showed no lesions. These results suggest that immunization with L1 DNA vaccines may prevent the development of papillomavirus-associated oral cancer.
ISSN:0300-0605
1473-2300
DOI:10.1177/147323000503300606